Skip to main content

Advertisement

SpringerLink
Log in

Peripheral Artery Disease and African Americans: Review of the Literature

  • Race and Ethnicity Disparities (M. Albert, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

A Correction to this article was published on 31 October 2019

This article has been updated

Abstract

Purpose of Review

Peripheral artery disease (PAD) is a chronic, obstructive disease of the peripheral vasculature which is a coronary heart disease risk equivalent. African Americans (AA) are at the highest risk for developing this disease at every age group. The purpose of this review is to shed light on the risk factors for PAD and their implications for disease manifestation in AA, and to highlight ways to combat these known racial disparities in order to achieve cardiovascular health equity in this population.

Recent Findings

Even after controlling for differences in the prevalence of known cardiovascular risk factors, AA are still significantly more likely to have PAD. In part, due to a disproportionate amount of cardiovascular risk factors and detrimental socioeconomic factors, AA with PAD have a worse prognosis and more unfavorable outcomes than other ethnic groups with PAD. AA with PAD are more likely to have limb loss with amputation and less likely to receive revascularization leading to limb salvage.

Summary

Advanced age, cigarette smoking, diabetes, hypertension, hyperlipidemia, chronic kidney disease, and poor socioeconomic status or education level have all been associated with increased risk of PAD. AA have a higher likelihood of having many, but not all, of these conditions. Nevertheless, increased cardiovascular risk for PAD combined with a relative lack of awareness about the disease in the AA community leads to poor health outcomes. Targeted interventions that partner healthcare access and delivery in community-based, non-traditional health care settings as well as the traditional clinics and hospitals may prove to be a more successful means of outreach in this high-risk population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

  • 31 October 2019

    The original version of this article unfortunately contained mistake in the presentation of the author’s name.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Steg PG, Bhatt DL, Wilson PW. REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–206.

    Article  CAS  PubMed  Google Scholar 

  2. Schuyler Jones W, Patel MR, Dai D, Subherwal S, Stafford J, et al. Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000–2008. J Am Coll Cardiol. 2012;60:2230–6.

    Article  PubMed  Google Scholar 

  3. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–40.

    Article  PubMed  Google Scholar 

  4. Subherwal S, Patel MR, Kober L, Peterson ED, Bhatt DL, Gislason GH, et al. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. Eur J Prev Cardiol. 2015;22(3):317–25.

    Article  PubMed  Google Scholar 

  5. Aboyans V, Ricco J, Bartelink MEL, Bjorck M, Brodmann M, Cohner T, et al. Eur Heart J. 2018;39(9):763–816.

    Article  PubMed  Google Scholar 

  6. Giannopoulos A, Kakkos S, Abbott A, Naylor AR, Richards T, Mikhailidis DP, et al. Long-term mortality in patients with asymptomatic carotid stenosis: implications for statin therapy. Eur J Vasc Endovasc Surg. 2015;50:573–82.

    Article  CAS  PubMed  Google Scholar 

  7. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197–208.

    Article  CAS  PubMed  Google Scholar 

  8. Murabito JM, Evans JC, Larson MG, Nieto K, Levy D, Wilson PWF. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med. 2003;163:1939–42.

    Article  PubMed  Google Scholar 

  9. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/AphA/ASPC/NLA/PCNA. Guideline on the management of blood cholesterol. Circulation. 2018. https://doi.org/10.1161/CIR.0000000000000625 [Epub ahead of print].

  10. •• Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, et al. AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2016;135:e726–79. Current ACC/AHA guidelines on detailed recommendations for diagnosis and treatment of patients with peripheral artery disease.

    PubMed  PubMed Central  Google Scholar 

  11. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999–3058.

    Article  PubMed  Google Scholar 

  12. Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32(4):328–33.

    Article  PubMed  Google Scholar 

  13. • Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, Langer RD, et al. Ethnicity and peripheral artery disease: the San Diego population study. Circulation. 2005;112:2703–7. In this landmark paper, Criqui and colleagues are the first to show that AA ethnicity is a strong and independent risk factor for PAD and that the excess risk of PAD in AA is not explained by higher levels of diabetes, hypertension, BMI, and other cardiovascular disease risk factors.

    Article  PubMed  Google Scholar 

  14. Allison MA, Criqui MH, McClelland RL, Scott JM, McDermott MM, Liu K, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2006;48:1190–7.

    Article  PubMed  Google Scholar 

  15. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and nutrition examination survey, 1999–2000. Circulation. 2004;110:738–43.

    Article  PubMed  Google Scholar 

  16. Kullo IJ, Bailey KR, Kardi SLR, Mosley TH, Boerwinkle E, Turner ST. Ethnic differences in peripheral arterial disease in the NHLBI genetic epidemiology network of arteriopathy (GENOA) study. Vasc Med. 2003;8:237–42.

    Article  PubMed  Google Scholar 

  17. Kalbaugh CA, Kucharska-Newton A, Wruck L, Lund JL, Selvin E, Matsushita K, Bengtson GS, Heiss G, Loehr L. Peripheral artery disease prevalence and incidence estimated from both outpatient and inpatient settings among Medicare fee-for-service beneficiaries in the atherosclerosis risk in communities (ARIC) study. J Am Heart Assoc 2017;6e003796. doi:https://doi.org/10.1161/JAHA.116003796.

  18. Collins TC, Slovut DP, Newton R Jr, Johnson WD, Larrivee S, Patterson J, et al. Ideal cardiovascular health and peripheral artery disease in African Americans: results from the Jackson Heart Study. Prev Med Rep. 2017;7:20–5.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ix JH, Allison MA, Denenberg JO, Cushman M, Criqui MH. Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J Am Coll Cardiol. 2008;51(24):2347–54.

    Article  PubMed  Google Scholar 

  20. Rucker-Whitaker C, Greenland P, Liu K, Chan C, Guralnik JM, Criqui MH, et al. Peripheral arterial disease in African Americans: clinical characteristics, leg symptoms, and lower extremity functioning. J Am Geriatr Soc. 2004;52:922–30.

    Article  PubMed  Google Scholar 

  21. McDermott MM, Polonsky TS, Kibbe MR, Tian L, Zhao L, Pearce WH, et al. Racial differences in functional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017;66(3):826–34.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association [published correction appears in Circulation 2017;136:e196]. Circulation. 2017;135:e146–603. https://doi.org/10.1161/CIR.0000000000000485.

    Article  PubMed  PubMed Central  Google Scholar 

  23. •• Carnethon MR, Pu J, Howard G, Albert MA, CAM A, Bertoni AG, et al. Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation. 2017;136:e393-e423. https://doi.org/10.1161/CIR.0000000000000534 Carnethon and colleagues thoughtfully examine the cardiovascular healthcare disparities that impact African Americans including but not limited to peripheral artery disease, coronary heart disease, and stroke.

    Article  PubMed  Google Scholar 

  24. Collins TC, Johnson M, Henderson W, et al. Lower extremity nontraumatic amputation among veterans with peripheral arterial disease: is race an independent factor? Med Care. 2002 Jan;40(1 Suppl):I106–16.

    PubMed  Google Scholar 

  25. Feinglass J, Abadin S, Thompson J, Pearce WH. A census-based analysis of racial disparities in lower extremity amputation rates in Northern Illinois, 1987–2004. J Vasc Surg. 2008;47:1001–7.

    Article  PubMed  Google Scholar 

  26. Rowe VL, Weaver FA, Lane JS, Etzioni DA. Racial and ethnic differences in patterns of treatment for acute peripheral arterial disease in the United States, 1998–2006. J Vasc Surg. 2010;51:21S–6S.

    Article  PubMed  Google Scholar 

  27. Mustapha JA, Fisher BT Sr, Rizzo JA, Chen J, Martinsen BJ, Kotlarz H, et al. Explaining racial disparities in amputation rates for the treatment of peripheral artery disease (PAD) using decomposition methods. J Racial Ethn Health Disparities. 2017;4(5):784–95.

    Article  PubMed Central  Google Scholar 

  28. Holman KH, Henke PK, Dimick JB, Birkmeyer JD. Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg. 2011;54:420–6. https://doi.org/10.1016/j.jvs.2011.02.035.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Durazzo TS, Frencher S, Gusberg R. Influence of race on the management of lower extremity ischemia: revascularization vs amputation. JAMA Surg. 2013;148:617–23. https://doi.org/10.1001/jamasurg.2013.1436.

    Article  PubMed  Google Scholar 

  30. Newhall K, Splangler E, Dzebishashvili N, Goodman DC, Goodney P. Amputation rates for patients with diabetes and peripheral arterial disease: the effects of race and region. Ann Vasc Surg. 2016;30:292–8.

    Article  PubMed  Google Scholar 

  31. Guadagnoli E, Ayanian JZ, Gibbons G, McNeil BJ, LoGerfo FW. The influence of race on the use of surgical procedures for treatment of peripheral vascular disease of the lower extremities. Arch Surg. 1995;130:381–6.

    Article  CAS  PubMed  Google Scholar 

  32. Huber TS, Wang JG, Wheeler KG, Cuddeback JK, Dame DA, Ozaki CK, et al. Impact of race on the treatment for peripheral arterial occlusive disease. J Vasc Surg. 1999;30:417–25.

    Article  CAS  PubMed  Google Scholar 

  33. Hughes K, Seetahal S, Oyetuni T, Rose D, Greene W, et al. Racial/ethnic disparities in amputation and revascularization: a nationwide inpatient sample study. Vasc Endovasc Surg. 2014;48:34–7.

    Article  Google Scholar 

  34. Rivero M, Nader ND, Blochle R, Harris LM, Dryjski ML, Dosluoglu HH. Poorer limb salvage in African American men with chronic limb ischemia is due to advanced clinical stage and higher anatomic complexity at presentation. J Vasc Surg. 2016;63:1318–24.

    Article  PubMed  Google Scholar 

  35. Loja MN, Brunson A, Li CS, Carson JG, White RH, Romano PS, et al. Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005–2009. Ann Vasc Surg. 2015;29:950–9.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Nejim B, Beaulieu RJ, Alshaikh H, Hamouda M, Canner J, Malas MB. A unique all-payer rate-setting system controls the cost but not the racial disparity in lower extremity revascularization procedures. Ann Vasc Surg. 2018;52:116–25.

    Article  PubMed  Google Scholar 

  37. Selvarajah S, Black JH 3rd, Haider AH, Abularrage CJ. Racial disparity in early graft failure after infrainguinal bypass. J Surg Res. 2014;190:335–43.

    Article  PubMed  Google Scholar 

  38. Cotter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A, et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction (OPUS-TIMI) 16 study. Am Heart J. 2003;145:622–7.

    Article  CAS  PubMed  Google Scholar 

  39. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114:688–99.

    Article  PubMed  Google Scholar 

  40. Grenon SM, Vittinghoff E, Owens CD, Conte MS, Whooley M, Cohen BE. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med. 2013;18:176–84.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, et al. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012;308:1768–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Peripheral artery disease fact sheet. Centers for Disease Control and Prevention. https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_pad.htm. [Accessed 2019 April 4].

  43. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34:509–15.

    Article  CAS  PubMed  Google Scholar 

  44. Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J. 1999;20:344–53.

    Article  CAS  PubMed  Google Scholar 

  45. Gornik HL, Creager MA. Medical treatment of peripheral artery disease. In: Creager MA, Beckman JA, Loscalzo J, editors. Vascular medicine: a companion to Braunwald’s heart disease. 2nd ed. Philadelphia: Elsevier; 2013. p. 242–8.

    Chapter  Google Scholar 

  46. Rice TW, Lumsden AB. Optimal medical management of peripheral arterial disease. Vasc Endovasc Surg. 2006;40:312–27.

    Article  Google Scholar 

  47. Clark D 3rd, Cain LR, Blaha MJ, DeFilippis AP, Mentz RJ, Kamimura D, et al. Cigarette smoking and subclinical peripheral arterial disease in blacks of the Jackson heart study. J Am Heart Assoc. 2019;8(3):e010674. https://doi.org/10.1161/JAHA.118.010674.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation. 2004;109:2511–7.

    Article  PubMed  Google Scholar 

  49. Schoenborn CA, Adams PF, Peregoy JA. Health behaviors of adults: United States, 2008–2010 [PDF–3.21 MB]. National Center for Health Statistics. Vital Health Stat 10(257) [Accessed 2018 Sept 12].

  50. Jamal A, Agaku IT, O’Connor E, King BA, Kenemer JB, Neff L. Current cigarette smoking among adults—United States, 2005–2013. MMWR Morb Mortal Wkly Rep 2014;63(47):1108–1112. www.cdc.gov/mmwr/preview/mmwrhtml/mm6347a4.htm. [Accessed 2019 April 13].

  51. Huen KH, Chowdhury R, Shafii SM, Brewster LP, Arya S, Duwayri Y, et al. Smoking cessation is the least successful outcome of risk factor modification in uninsured patients with symptomatic peripheral arterial disease. Ann Vasc Surg. 2015;29:42–9.

    Article  PubMed  Google Scholar 

  52. Kulak JA, Cornelius ME, Fong GT, Giovino GA. Differences in quit attempts and cigarette smoking abstinence between Whites and African Americans in the United States: literature review and results from the international tobacco control US survey. Nicotine Tob Res. 2016;(Suppl 1):S79–87. https://doi.org/10.1093/ntr/ntv228.

    Article  Google Scholar 

  53. Caraballo RS, Kruger J, Asman K, Pederson L, Widome R, Kiefe CI, et al. Relapse among cigarette smokers: the CARDIA longitudinal study - 1985–2011. Addict Behav. 2014;39(1):101–6.

    Article  PubMed  Google Scholar 

  54. Nollen NL, Mayo MS, Cox LS, Benowitz NL, Tyndale RF, Ellerbeck EF, et al. Factors that explain differences in abstinence between Black and White smokers: a prospective intervention study. J Natl Cancer Inst. 2019. https://doi.org/10.1093/jnci/djz001 [Epub ahead of print].

    Article  PubMed  PubMed Central  Google Scholar 

  55. Levy DT, Blackman K, Tauras J, Chaloupka FJ, Villanti AC, Niaura RS, et al. Quit attempts and quit rates among menthol and nonmenthol smokers in the United States. Am J Public Health. 2011;101(7):1241–7.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47:921–9.

    Article  PubMed  Google Scholar 

  57. Silbernagel G, Rein P, Saely CH, Engelberger RP, Willenberg T, Do DD, et al. Prevalence of type 2 diabetes is higher in peripheral artery disease than in coronary artery disease patients. Diab Vasc Dis Res. 2015;12:146–9.

    Article  PubMed  Google Scholar 

  58. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314:1021–9.

    Article  CAS  PubMed  Google Scholar 

  59. Howard G, Safford MM, Moy CS, Howard VJ, Kleindorfer DO, Unverzagt FW, et al. Racial differences in the incidence of cardiovascular risk factors in older black and white adults. J Am Geriatr Soc. 2017;65(1):83–90.

    Article  PubMed  Google Scholar 

  60. Althouse AD, Abbott JD, Forker AD, Bertolet M, Barinas-Mitchell E, Thurston RC, et al. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the bypass angioplasty revascularization investigation in type 2 diabetes (BARI 2D) trial. Diabetes Care. 2014;37:1346–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Forsythe RO, Hinchliffe RJ. Assessment of foot perfusion in patients with a diabetic foot ulcer. Diabetes Metab Res Rev. 2016;32:232–8.

    Article  CAS  PubMed  Google Scholar 

  62. van der Feen C, Neijens FS, Kanters SD, Mali WP, Stolk RP, Banga JD. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes. Diabet Med. 2002;19:366–70.

    Article  PubMed  Google Scholar 

  63. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24:1433–7.

    Article  CAS  PubMed  Google Scholar 

  64. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333–41.

    Article  Google Scholar 

  65. Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97:E1579–639. https://doi.org/10.1210/jc.2012-2043.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–28.

    Article  CAS  PubMed  Google Scholar 

  67. Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;17(377):644–57.

    Article  Google Scholar 

  68. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000;85:251–5.

    Article  CAS  PubMed  Google Scholar 

  69. Weissgerber TL, Turner ST, Bailey KR, Mosley TH Jr, Kardia SLR, Wiste HJ, et al. Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy. Atherosclerosis. 2013;229:212–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update. Circulation. 2014;129:e28–e292.

    Article  PubMed  CAS  Google Scholar 

  71. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, et al. ACC/AHA/AAPA/ABC/ACPM/AGS Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138:e426–83.

    PubMed  Google Scholar 

  72. Meijer WT, Grobbee DE, Hunink MG, Hofman A, Hoes AW. Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med. 2000;160:2934–8.

    Article  CAS  PubMed  Google Scholar 

  73. Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc. 2007;55:583–9.

    Article  PubMed  Google Scholar 

  74. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA tTask Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463–654.

    Article  PubMed  Google Scholar 

  75. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398–404.

    Article  CAS  PubMed  Google Scholar 

  76. Itoga NK, Tawfik DS, Lee CK, Maruyama S, Leeper NJ, Chang TI. Association of blood pressure measurements with peripheral artery disease events. Reanalysis of the ALLHAT data. Circulation. 2018;138:1805–14.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Fudim M, Jones WS. New curveball for hypertension guidelines? Circulation. 2018;138:1815–8.

    Article  PubMed  Google Scholar 

  78. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104:1108–13.

    Article  CAS  PubMed  Google Scholar 

  79. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005;112:3375–83.

    Article  CAS  PubMed  Google Scholar 

  80. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002:3607–22.

  81. Murphy SA, Cannon CP, Blazing MA, Giugliano RP, White JA, Lokhnygina Y, et al. Reduction in total cardiovascular events with ezetimibe/simvastatin post-acute coronary syndrome: the IMPROVE-IT trial. J Am Coll Cardiol. 2016;67:353–61.

    Article  CAS  PubMed  Google Scholar 

  82. Sabatine MS, Giugliano RP, Keech A, Honarpour N, Wang H, Liu T, et al. Rationale and design of the further cardiovascular OUtcomes research with PCSK9 inhibition in subjects with elevated risk trial. Am Heart J. 2016;173:194–01.

    Article  CAS  Google Scholar 

  83. Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular OUtcomes research with PCSK9 inhibition in subjects with elevated risk). Circulation. 2018;137:338–50.

    Article  CAS  PubMed  Google Scholar 

  84. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45:645–54.

    Article  Google Scholar 

  85. Arya S, Khakharia A, Binney ZO, DeMartino RR, Brewster LP, Goodney PP, et al. Association of statin dose with amputation and survival in patients with peripheral artery disease. Circulation. 2018;137:1435–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD. Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006. NCHS Data Brief. 2010;36:1–8.

    Google Scholar 

  87. de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation. 2016;133:1067–72.

    Article  PubMed  CAS  Google Scholar 

  88. Amrock SM, Duell PB, Knickelbine T, Martin SS, O'Brien EC, Watson KE, et al. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry. Atherosclerosis. 2017;267:19–26.

    Article  CAS  PubMed  Google Scholar 

  89. Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, et al. Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use insights from the patient and provider assessment of lipid management registry. JAMA Cardiol. 2018;3(8):739–48.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Norton JM, Moxey-Mims MM, Eggers PW, Narva AS, Star RA, Kimmel PL, et al. Social determinants of racial disparities in CKD. J Am Soc Nephrol. 2016;27:2576–95.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, et al. US renal data system 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2015;66(Suppl 1):S1–S305.

    Google Scholar 

  92. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902–7.

    Article  PubMed  Google Scholar 

  93. McClellan W, Warnock DG, McClure L, Campbell RC, Newsome BB, Howard V, et al. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study. J Am Soc Nephrol. 2006;17:1710–5.

    Article  PubMed  Google Scholar 

  94. Derose SF, Rutkowski MP, Crooks PW, Shi JM, Wang JQ, Kalantar-Zadeh K, et al. Racial differences in estimated GFR decline, ESRD, and in an integrated health system. Am J Kidney Dis. 2013;62:236–44.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Garimella PS, Hart PD, O'Hare A, DeLoach S, Herzog CA, Hirsch AT. Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care. Am J Kidney Dis. 2012;60:641–54.

    Article  PubMed  Google Scholar 

  96. O’Hare AM. Management of peripheral arterial disease in chronic kidney disease. Cardiol Clin. 2005;23:225–36.

    Article  PubMed  Google Scholar 

  97. Leskinen Y, Salenius JP, Lehtimäki T, Huhtala H, Saha H. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis. 2002;40:472–9.

    Article  PubMed  Google Scholar 

  98. O’Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation. 2004;109:320–3.

    Article  PubMed  Google Scholar 

  99. Lacroix P, Aboyans V, Desormais I, Kowalsky T, Cambou JP, Constans J, et al. Chronic kidney disease and the short-term risk of mortality and amputation in patients hospitalized for peripheral artery disease. J Vasc Surg. 2013;58:966–71.

    Article  PubMed  Google Scholar 

  100. Lüders F, Bunzemeier H, Engelbertz C, Malyar NM, Meyborg M, Roeder N, Berger K, Reinecke H. CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia.

  101. Lüders F, Bunzemeier H, Engelbertz C, Malyar NM, Meyborg M, Roeder N, et al. The impact of chronic kidney disease on hospitalized patients with peripheral arterial disease and critical limb ischemia. Angiology. 2017;68:145–50.

    Article  PubMed  Google Scholar 

  102. Arinze NV, Gregory A, Francis JM, Farber A, Chitalia VC. Unique aspects of peripheral artery disease in patients with chronic kidney disease. Vasc Med. 2019;24:251–60. https://doi.org/10.1177/1358863X18824654. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  103. Pande RL, Creager MA. Socioeconomic inequality and peripheral artery disease prevalence in US adults. Circ Cardiovasc Qual Outcomes. 2014;7:532–9.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Henry AJ, Hevelone ND, Belkin M, Nguyen LL. Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. J Vasc Surg. 2011;53(2):330–9.

    Article  PubMed  Google Scholar 

  105. Regenbogen SE, Gawande AA, Lipsitz SR, Greenberg CC, Jha AK. Do differences in hospital and surgeon quality explain racial disparities in lower-extremity vascular amputations? Ann Surg. 2009;250:424–31.

    PubMed  Google Scholar 

  106. Vart P, Coresh J, Kwak L, Ballew SH, Heiss G, Matsushita K. Socioeconomic status and incidence of hospitalization with lower-extremity peripheral artery disease: atherosclerosis risk in communities study. J Am Heart Assoc. 2017;10:6:pii: e004995. https://doi.org/10.1161/JAHA.116.004995.

    Article  Google Scholar 

  107. Roger VL, Go AS, Lloyd-Jones DM, Roger VL, Go AS, Benjamin EJ, et al. Heart disease and stroke statistics 2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–e209. https://doi.org/10.1161/CIR.0b013e3182009701.

    Article  PubMed  Google Scholar 

  108. Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood EM, et al. Peripheral arterial disease coalition. Gaps in public knowledge of peripheral arterial disease. Circulation. 2007;116:2086–94.

    Article  PubMed  Google Scholar 

  109. Lipworth L, Fazio S, Kabagambe EK, Munro HM, Nwazue VC, et al. A prospective study of statin use and mortality among 67,385 blacks and whites in the Southeastern United States. Clin Epidemiol. 2013;6:15–25.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Goyal A, Cooper HA, Aronow WS, Nagal P, Yandrapalli S, et al. Use of statins for primary prevention: selection of risk threshold and implications across race and gender. Am J Med. 2018;S0002–9343(18):30518–7.

    Google Scholar 

  111. Soden PA, Zettervall SL, Deery SE, Hughes K, Stoner MC, Goodney PP, et al. Black patients present with more severe vascular disease and a greater burden of risk factors than white patients at time of major vascular intervention. J Vasc Surg. 2018;67(2):549–556.e3. https://doi.org/10.1016/j.jvs.2017.06.089.

    Article  PubMed  Google Scholar 

  112. Eastridge DK. An integrative review of interventions to reduce peripheral arterial disease risk factors in African Americans. J Vasc Nurs. 2009 Jun;27:31–45.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

I would like to thank Dr. Lee Kirksey, Dr. Heather L. Gornik, and Dr. Jackson T. Wright, Jr. for their valuable comments and revisions on the manuscript.

Author information

Authors and Affiliations

  1. Sections of Vascular Medicine and Cardiology, Department of Cardiovascular Medicine, University Hospitals Harrington Heart and Vascular Institute, 11100 Euclid Avenue, Mailstop LKS 5038, Cleveland, OH, 44106, USA

    Khendi White Solaru

Authors
  1. Khendi White Solaru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khendi White Solaru.

Ethics declarations

Conflict of Interest

Dr. White Solaru declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Race and Ethnicity Disparities

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Solaru, K.W. Peripheral Artery Disease and African Americans: Review of the Literature. Curr Cardiovasc Risk Rep 13, 27 (2019). https://doi.org/10.1007/s12170-019-0621-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12170-019-0621-1

Keywords

Search

Navigation